01-03-2023 Σουηδικό Υπουργείο Υγείας: Οι νέες συστάσεις για εμβολιασμό κατά του covid19.
(περίοδος ισχύος: από 01/03/2023 έως 29/02/2024):
Το μεταφράζω στα Αγγλικά:The new recommendations apply from 1 March 2023 to 29 February 2024. Here you will find information on which age groups are recommended for vaccination.
The vaccination against covid-19 protects against serious illness and death. Nowadays, almost everyone in Sweden has good protection against covid-19. The latest survey on immunity to covid-19 shows that at least 94 percent of those examined have antibodies. Among children and young adults, protection has been built up mainly through one or more covid-19 infections. In the elderly there is protection through both infection and vaccination.
However, t
he protection needs to be topped up with additional doses in the next year for people aged 50 and over. This also applies to people younger than 50 who belong to a risk group.The Public Health Agency continuously analyzes the development of the SARS-CoV-2 virus, the vaccines and how the epidemic develops. New knowledge means that the Public Health Agency continuously changes its recommendations on vaccination against covid-19. The new recommendations apply no more than one year ahead, from 1 March 2023 to 29 February 2024.
New recommendations valid from 1 March 2023
Here are the authority's recommendations for different age groups and risk groups. The recommendations apply from March 1, 2023 and until February 29, 2024 at the latest:
80 years and older, as well as residents at Nursing Homes:People who are 80 years of age and older and people living in Nursing Homes (special housing for the elderly), two doses are recommended during the period March 1, 2023–February 29, 2024. The recommendation applies regardless of the previous number of doses.
Time interval between the two doses: at least 6 months.
This age group is recommended to have a basic vaccination with three doses: primary vaccination (two doses) followed by a booster dose after four months at the earliest.
65–79 years and people in the risk group from 18 years of agePeople aged 65–79 and people in the risk group who are 18 years and older, a dose is recommended during the period 1 March 2023–29 February 2024. The dose should primarily be given before the autumn and winter season 2023/24. The recommendation applies regardless of the previous number of doses.
An additional dose of vaccine is available to be taken between March 1, 2023 and February 29, 2024.
Time interval for vaccination: at least 6 months since the last dose.
This age group is recommended to have a basic vaccination with three doses: primary vaccination (two doses) followed by a booster dose after four months at the earliest.
50–64 yearsPeople aged 50–64 are recommended a dose during the period 1 March 2023–29 February 2024. The dose should primarily be given before the autumn and winter season 2023/24. The recommendation applies regardless of the previous number of doses.
Time interval for vaccination: at least 9 months since the last dose.
This age group is recommended to have a basic vaccination with three doses: primary vaccination (two doses) followed by a booster dose at the earliest after four months, but preferably with a longer interval.
18–49 yearsFor people aged 18–49, there is no recommendation for a top-up dose. The recommendation for three doses of basic vaccination also ceases as of March 1, 2023. One dose is available during the period March 1, 2023-February 29, 2024, regardless of the previous number of doses and can be taken, for example, if you live near an elderly person or persons in a risk group.
Time interval for vaccination: at least 9 months since the last dose.
Basic vaccination with 3 doses is still available.
Read more about risk groups:
Pregnant regardless of age after week 12 of pregnancy.
Adults with the following diseases or conditions:
Chronic cardiovascular disease including high blood pressure.
Chronic lung disease, such as COPD and severe/unstable asthma.
Other conditions that lead to impaired lung function or impaired cough force and secretion stagnation (for example, extreme obesity, neuromuscular diseases or multiple functional disabilities).
Chronic liver or kidney failure.
Diabetes mellitus type 1 and 2.
Down syndrome.
Stroke/dementia.
People with a weakened immune system due to illness or treatmentΔεν είναι ορατοί οι σύνδεσμοι (links).
Εγγραφή ή
ΕίσοδοςSpecial schedule for people with a weakened immune systemFor people with a weakened immune system, a weaker immune response is expected after a vaccination. They are therefore recommended vaccinations according to a special schedule with more doses according to special prescription. Read more: Δεν είναι ορατοί οι σύνδεσμοι (links).
Εγγραφή ή
ΕίσοδοςΔεν είναι ορατοί οι σύνδεσμοι (links).
Εγγραφή ή
Είσοδος
Θέμα: Κορονοϊός ( COVID-19 ) (Αναγνώστηκε 298677 φορές)
24 Απριλίου 2020, 01:44:56